These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Zuccato C; Marullo M; Conforti P; MacDonald ME; Tartari M; Cattaneo E Brain Pathol; 2008 Apr; 18(2):225-38. PubMed ID: 18093249 [TBL] [Abstract][Full Text] [Related]
23. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Angelucci F; Aloe L; Jiménez-Vasquez P; Mathé AA Int J Neuropsychopharmacol; 2003 Sep; 6(3):225-31. PubMed ID: 12974988 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Pillai A; Terry AV; Mahadik SP Schizophr Res; 2006 Feb; 82(1):95-106. PubMed ID: 16442781 [TBL] [Abstract][Full Text] [Related]
25. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. Angelucci F; Mathé AA; Aloe L J Neurosci Res; 2000 Jun; 60(6):783-94. PubMed ID: 10861791 [TBL] [Abstract][Full Text] [Related]
26. Chronic amphetamine treatment reduces NGF and BDNF in the rat brain. Angelucci F; Gruber SH; El Khoury A; Tonali PA; Mathé AA Eur Neuropsychopharmacol; 2007 Dec; 17(12):756-62. PubMed ID: 17434716 [TBL] [Abstract][Full Text] [Related]
27. Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain. Angelucci F; Aloe L; Iannitelli A; Gruber SH; Mathé AA Eur Neuropsychopharmacol; 2005 May; 15(3):311-7. PubMed ID: 15820421 [TBL] [Abstract][Full Text] [Related]
28. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Angelucci F; Mathé AA; Aloe L Prog Brain Res; 2004; 146():151-65. PubMed ID: 14699963 [TBL] [Abstract][Full Text] [Related]
29. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review. Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254 [TBL] [Abstract][Full Text] [Related]
30. Neurotrophic mechanisms in drug addiction. Bolaños CA; Nestler EJ Neuromolecular Med; 2004; 5(1):69-83. PubMed ID: 15001814 [TBL] [Abstract][Full Text] [Related]
31. Brain-Derived Neurotrophic Factor and Diabetes. Rozanska O; Uruska A; Zozulinska-Ziolkiewicz D Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012942 [TBL] [Abstract][Full Text] [Related]
32. Neurotrophic factors and status epilepticus. Simonato M Epilepsia; 2018 Oct; 59 Suppl 2():87-91. PubMed ID: 30159899 [TBL] [Abstract][Full Text] [Related]